A significant body of evidence points to the importance of upstream regulators of STAT3 in lung cancer development, for example, EGFR and Src,34 our study highlights JAK1 as a candidate kinase for STAT3 phosphorylation and activation in LUSC. Here, SRC is linked to lung cancer.